Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors
New research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborating organizations has identified a next-generation BTK degrader that could help overcome treatment ...
Feb 1, 2024
0
8